{"id":"NCT01952145","sponsor":"Novo Nordisk A/S","briefTitle":"A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus","officialTitle":"A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUALâ„¢ V - Basal Insulin Switch)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09-20","primaryCompletion":"2014-11-04","completion":"2014-11-04","firstPosted":"2013-09-27","resultsPosted":"2017-01-20","lastUpdate":"2019-01-03"},"enrollment":557,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec/liraglutide","otherNames":[]},{"type":"DRUG","name":"insulin glargine","otherNames":[]}],"arms":[{"label":"Insulin degludec/liraglutide OD plus metformin","type":"EXPERIMENTAL"},{"label":"Insulin glargine OD plus metformin","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted globally. The aim of the trial is to compare the efficacy and safety of insulin degludec/liraglutide versus insulin glargine in subjects with type 2 diabetes mellitus.","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Glycosylated Haemoglobin)","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"Insulin Degludec/Liraglutide (IDegLira)","deltaMin":-1.81,"sd":1.08},{"arm":"Insulin Glargine (IGlar)","deltaMin":-1.13,"sd":0.98}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":91,"countries":["United States","Argentina","Australia","Greece","Hungary","Mexico","Russia","Slovakia","South Africa","Spain"]},"refs":{"pmids":["26934259","28294641","28281218","28417535","28643425","29276398","30383495","39963952","36710452","31705547"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":278},"commonTop":["Nausea","Diarrhoea","Headache","Vomiting"]}}